In Publication: CGM Health Economics

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada – Journal of Comparative Effectiveness Research– September 5, 2023

Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada

Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada – Diabetes– June 20, 2023

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Cost-effectiveness of Real-Time Continuous Glucose Monitoring – CanadaCGM – October 2022

Cost Offset Analysis (COA) Comparing Real-Time Continuous Glucose Monitoring (RT-CGM) With Self-Monitoring of Blood Glucose (SMBG) in People With Type 1 Diabetes in Eight Countries

Cost Offset Analysis (COA) Comparing RT-CGM With SMBG in People With Type 1 Diabetes in Eight Countries – ATTD – 2020

Long-term Cost-Effectiveness of Dexcom G6 Continuous Glucose Monitor in Canada

Long-term Cost-Effectiveness of Dexcom G6 Continuous Glucose Monitor in Canada – www.capt-actp.ca – 2020🍁

Dexcom G6 for real-time continuous glucose monitoring

CGM Evaluations

Dexcom G6 for real-time continuous glucose monitoring – www.nice.org.uk – 2020

This site is intended for heath plan professionals in Canada.

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM

Watch Now

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada

Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Cost Offset Analysis (COA) Comparing Real-Time Continuous Glucose Monitoring (RT-CGM) With Self-Monitoring of Blood Glucose (SMBG) in People With Type 1 Diabetes in Eight Countries

Long-term Cost-Effectiveness of Dexcom G6 Continuous Glucose Monitor in Canada

Dexcom G6 for real-time continuous glucose monitoring

Footer Content

Provided by

This site is intended for heath plan professionals in Canada.

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence: CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and Reduces CVD Risk in Non-Insulin-Treated T2D

Next-Generation Dexcom G7 CGM System Approved by Health Canada

ADA 2023 Highlights: The Clinical and Economic Value of CGMWatch Now

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada

Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Cost Offset Analysis (COA) Comparing Real-Time Continuous Glucose Monitoring (RT-CGM) With Self-Monitoring of Blood Glucose (SMBG) in People With Type 1 Diabetes in Eight Countries

Long-term Cost-Effectiveness of Dexcom G6 Continuous Glucose Monitor in Canada

Dexcom G6 for real-time continuous glucose monitoring

Footer Content

Provided by

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM

Watch Now